Status:

COMPLETED

"Can Do" Versus "Do Do" in Patients With Breast Cancer

Lead Sponsor:

Hacettepe University

Conditions:

Breast Cancer

Exercise Capacity

Eligibility:

FEMALE

18-65 years

Brief Summary

Breast cancer occurs as a result of uncontrolled proliferation of cells in the breast tissue. Breast cancer is the most common type of cancer among women worldwide and is an important problem that thr...

Detailed Description

Breast cancer occurs as a result of uncontrolled proliferation of cells in the breast tissue. Breast cancer is the most common type of cancer among women worldwide and is an important problem that thr...

Eligibility Criteria

Inclusion

  • Being between 18-65 years of age,
  • Volunteering to participate in the research,
  • At least 15 months after breast cancer surgery,
  • Six months after active breast cancer treatment (i.e. surgery/chemotherapy),
  • No problems in reading and/or understanding the scales and being able to cooperate with the tests,

Exclusion

  • Presence of active infection,
  • Musculoskeletal and neurological diseases that may affect exercise performance, symptomatic heart disease,
  • Have a neurological disease or other clinical diagnosis that may affect cognitive status.
  • Musculoskeletal and neurologic disease, symptomatic heart disease, previous lung surgery and malignant disease that may affect exercise performance.
  • Presence of unstable hypertension or diabetes mellitus

Key Trial Info

Start Date :

June 15 2024

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

June 12 2025

Estimated Enrollment :

59 Patients enrolled

Trial Details

Trial ID

NCT06018051

Start Date

June 15 2024

End Date

June 12 2025

Last Update

July 8 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Ebru Çalık Kutukcu

Ankara, Hacettepe Unıversity, Turkey (Türkiye), 06100